|
| | | | PLENARY-ROOM | 17:00 - 17:20 OFFICIAL OPENING: WELCOME BY AUTHORITIES, DIRECTORS AND WG CHAIRMAN | | |
17:20 - 19:40 SESSION 1 - EMERGING CONCEPTS IN CARDIOMYOPATHIES | | | | | Elliott P. Classification of cardiomyopathies: news for the future | |
| | | | |
| | | | Ho C. Molecular basis of cardiomyopathies: new genes and technologies |
| | | | |
| | | | Olivotto I. Pharmacological treatment : high time for evidence | |
| | | | |
| | | | Bonow R. USA, Europe and the rest of the word: differences and similarities | |
| | | | |
| | | | Thiene G. Lessons from history: "GALILEO as a patient" | |
| | | | |
| |
|
| | | | |
| | | | ROOM-1 | 09:00 - 13:00 MINICOURSE - BASIC SCIENCE - THE CARDIOMYOCYTE AND ITS ENVIRONMENT: FROM PATHOPHYSIOLOGY TO NOVEL THERAPEUTIC TARGETS | | | | | Poggesi C. Anatomy and electromechanical properties |
| | | | |
| | | | Tardiff J. Electrical and mechanical dysfunction |
| | | | |
| | | | A. Donati, E. Pasquini Inborn error of metabolism |
| | | | |
| | | | Redwood C. Signalling pathways for left ventricular hypertrophy |
| | | | |
| | | | Cerbai E. Molecular targets for disease-specific treatment (RAAS, intracellular calcium metabolism, Slow Ina and other currents, prevention of microvascular ischemia and fibrosis) |
| | | | |
| | | | Coppini R. Molecular targets for disease-specific treatment (RAAS, intracellular calcium metabolism, Slow Ina and other currents, prevention of microvascular ischemia and fibrosis) |
| | | | |
| |
14:30 - 16:00 MINICOURSE - CLINICAL SCIENCE - HOW-TO SESSION: HOW TO PERFORM AND INTERPRET | | | | | Pepe G. Assessment of extracardiac phenotype |
| | | | |
| | | | Thiene G. Myocardial biopsy |
| | | | |
| |
|
| | | | |
| | | | ROOM-2 | 09:00 - 10:45 MINICOURSE - BASIC SCIENCE - MYOCARDIAL AND PERICARDIAL RESPONSES TO AUTOIMMUNE DISEASE AND INFECTION | | | | | Caforio A. Antibody-mediated response |
| | | | |
| | | | Pankuweit S. Cell-mediated response |
| | | | |
| | | | Klingel K. Role of viral agents |
| | | | |
| |
11:00 - 16:30 MINICOURSE - CLINICAL SCIENCE - HOW-TO SESSION: EVALUATION OF MYOCARDIAL AND PERICARDIAL DISEASES | | | | | Rapezzi C. A reappraisal of the ECG |
| | | | |
| | | | Nistri S. Hot to use Echocardiography for diagnosis and management |
| | | | |
| | | | Aquaro G. D. Cardiac Magnetic Resonance |
| | | | |
| | | | P. Camici, O. Rimoldi Nuclear Medicine and PET |
| | | | |
| | | | Pieragnoli P. ICD and CRT monitoring and optimization |
| | | | |
| | | | Cappato R. Ablation of atrial and ventricular arrhythmias in patient with cardiomyopathy |
| | | | |
| | | | Gimeno J. R. Illustrative case studies |
| | | | |
| |
|
| | | | |
| | | | ROOM-3 | 11:00 - 13:00 SATELLITE SYMPOSIUM INDUSTRY SPONSORED - ANDERSON-FABRY DISEASE: A NEW CHALLENGE FOR THE CARDIOLOGIST - SESSION 1- SPONSORED BY GENZYME | | | | | Elliott P. Epidemiology of Fabry disease: which patients should be tested? |
| | | | |
| | | | Morrone A. Lab tests for diagnosis: the need for quality excellence |
| | | | |
| | | | Namdar M. ECG changes for early recognition and differentiation of Fabry disease, amyloidosis and hypertrophic cardiomyopathy |
| | | | |
| | | | Cecchi F. Microvascular dysfunction |
| | | | |
| |
14:30 - 16:30 SATELLITE SYMPOSIUM INDUSTRY SPONSORED - ANDERSON-FABRY DISEASE: A NEW CHALLENGE FOR THE CARDIOLOGIST - SESSION 2 - SPONSORED BY GENZYME | | | | | Cecchi F. Heart disease : clinical management and outcome |
| | | | |
| | | | Burlina A. Neuropathic pain and stroke management |
| | | | |
| | | | Mignani R. Timing of ERT treatment and outcome on renal function |
| | | | |
| | | | Weidemann F. Optimal timing of ERT therapy: lessons from patients follow-up |
| | | | |
| |
|
| | | | |
|
|